Koninklijke Philips (RYLPF) Gains from Investment Securities (2009 - 2026)
Koninklijke Philips (RYLPF) recorded quarterly Gains from Investment Securities of $15.2 million in Q1 2026, down 49.71% quarter-over-quarter from $30.3 million in Q4 2025, and up 823.45% on a YoY basis from $1.6 million in Q1 2025.
Koninklijke Philips (RYLPF) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Koninklijke Philips' Gains from Investment Securities history runs 18 years deep, the most recent figure standing at $15.2 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 823.45% year-over-year to $15.2 million; the TTM figure through Mar 2026 stood at $44.3 million (up 290.89% YoY), while the FY2025 annual figure was $26.8 million, up 231.87% from the prior year.
- Gains from Investment Securities was $15.2 million for Q1 2026 at Koninklijke Philips, down from $30.3 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $30.3 million in Q4 2025 to a low of -$117.3 million in Q4 2022.
- Historically, Gains from Investment Securities has averaged -$15.1 million across 5 years, with a median of -$2.2 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities sank 121.29% in 2025, then surged 823.45% in 2026.
- A 5-year view of Gains from Investment Securities shows it stood at -$117.3 million in 2022, then soared by 34.89% to -$76.4 million in 2023, then soared by 60.83% to -$29.9 million in 2024, then surged by 201.15% to $30.3 million in 2025, then tumbled by 49.71% to $15.2 million in 2026.
- The last three Gains from Investment Securities figures came in at $15.2 million (Q1 2026), $30.3 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Koninklijke Philips | - | - | 2.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.22 Mn |
| Mar 31, 2026 | 15.22 Mn |
| Dec 31, 2025 | 30.27 Mn |
| Dec 31, 2025 | 30.27 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | -2.10 Mn |
| Mar 31, 2025 | -2.10 Mn |
| Dec 31, 2024 | -29.92 Mn |
| Dec 31, 2024 | -29.92 Mn |
| Sep 30, 2024 | 10.98 Mn |
| Sep 30, 2024 | 10.98 Mn |
| Jun 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | -2.15 Mn |
| Mar 31, 2024 | -1.09 Mn |
| Mar 31, 2024 | -1.09 Mn |
| Dec 31, 2023 | -76.39 Mn |
| Dec 31, 2023 | -76.39 Mn |